Assunto: IMUNOLOGIA
ABNT
CAMPOS, H. S. et al. Aedes aegypti saliva as a therapeutic option in the treatment of experimentally induced inflammatory bowel disease. 2012, Anais.. Glasgow: European Federation of Immunological Societies, 2012. . Acesso em: 04 nov. 2024.APA
Campos, H. S., Souza, P. R., Nunes, A. de S., & Cardoso, C. R. B. (2012). Aedes aegypti saliva as a therapeutic option in the treatment of experimentally induced inflammatory bowel disease. In . Glasgow: European Federation of Immunological Societies.NLM
Campos HS, Souza PR, Nunes A de S, Cardoso CRB. Aedes aegypti saliva as a therapeutic option in the treatment of experimentally induced inflammatory bowel disease. 2012 ;[citado 2024 nov. 04 ]Vancouver
Campos HS, Souza PR, Nunes A de S, Cardoso CRB. Aedes aegypti saliva as a therapeutic option in the treatment of experimentally induced inflammatory bowel disease. 2012 ;[citado 2024 nov. 04 ]